ANKURDRUGS
ANKURDRUGS · NSE · inactive
3.65
-0.15 (-3.95%)
as of 10 Sept 2013 close
Open
3.75
High
3.75
Low
3.65
Prev close
3.80
52w high
20.25
04 Oct 2012
52w low
3.65
04 Sept 2013
VWAP
3.65
Delivery %
—
n/a
Volume 10,260 · turnover ₹37,499 · NSE bhavcopy (official close) · history since 22 May 2007
- Series
- EQ
- F&O
- No
- Status
- Inactive since 11 Sept 2013
Source: NSE equity master · as of 10 Sept 2013
Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 10:43 IST
AllM&AAGM / meetingAnalyst meetBoard meetingBusiness updateManagementComplianceCorporate actionCredit ratingDividendExchange queryGeneral updateInsider / SASTLegalOrder winResults
- 25 Oct 2012 13:37PDF · -Insider / SAST
AAKanksha Securities Private Limited has submitted to the Exchange vide letter dated October 23, 2012 a copy of Disclosure pursuant to Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
- 25 Oct 2012 13:37PDF · -Insider / SAST
Anupama Furnandu Jain has submitted to the Exchange vide letter dated October 23, 2012 a copy of Disclosure pursuant to Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
- 07 Feb 2011 12:09PDF · -Insider / SAST
Ankur Drugs And Pharma Limited has submitted to the Exchange a copy of disclosure under Regulation 8A(4) of SEBI (Substantial Acquisition and Takeover) Regulations, 1997.
Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
- Results & board-meeting calendar
- Dividend, split, AGM calendar
- Headlines with source and timestamp
- Two-line factual filing summaries